Taurine
SIGMA/T0625 - ≥99%
Synonym: 2-
CAS Number: 107-35-7
Empirical Formula (Hill Notation): C2H7NO3S
Molecular Weight: 125.15
EC Number: 203-483-8
MDL Number: MFCD00008197
Linear Formula: NH2CH2CH2SO3H
Product Type: Chemical
application(s) | cell analysis |
assay | ≥99% |
biological source | synthetic |
color | white |
form | powder |
InChI | 1S/C2H7NO3S/c3-1-2-7(4,5) |
InChI key | XOAAWQZATWQOTB-UHFFFAOYSA |
mp | >300 °C (lit.) |
Quality Level | 200 ![]() |
SMILES string | NCCS(O)(=O)=O |
storage temp. | room temp |
Application: | Taurine has been used for the isolation and growth of taurine-utilizing purple non-sulfur bacteria and in phototrophic growth experiments. |
Biochem/physiol Actions: | Non-selective endogenous agonist at glycine receptors. Conditionally essential sulfonated amino acid which modulates apoptosis in some cells; functions in many metabolic activities; a product of methionine and cysteine metabolism. |
Biochem/physiol Actions: | Taurine modulates the concentration of intracellular calcium, protects against ischemia-reperfusion injury and possesses blood pressure-lowering properties. It also has a role in bile formation and fat digestion. Deficiency of taurine is associated with anxiety, hyperactivity, epilepsy and depression. |
General description: | Taurine (2-aminoethanesulphonic acid) is predominantly found in the retina and heart and is also found in the brain, intestine, skeletal muscles and kidneys. |
Packaging: | 1 kg in poly bottle |
Packaging: | 10 mg in poly bottle |
Packaging: | 10, 25, 100, 500 g in poly bottle |
Hazard Codes | Xi |
Risk Statements | 36/37/38 |
Safety Statements | 26-36 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 2 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥99% |
mp | >300 °C (lit.) |
Storage Temp. | room temp |
UNSPSC | 12352106 |